Physician Assistant Program year 2025 Reported 2022–2025 Source: CMS Open Payments, 2026 publication

Trevor Day

Physician Assistant Moraine, OH Physician Assistant

NPI 1356097091 CMS profile 11348466

3095 Kettering Blvd, Moraine, OH 45439

Open in the dashboard

General payments

$6,324

359 records reported · program years 2022–2025

Research payments

$0

Paid to them · None reported · program years 2022–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Trevor Day of Moraine, OH is reported in the CMS Open Payments database as having received $6,324 across 359 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 94th percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,351 82
2024 General $1,713 94
2023 General $1,751 97
2022 General $1,510 86

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Trevor Day
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Trevor Day were reported at $1,351. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Trevor Day Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $0 $132 $37–$438 $132
2022 $1,510 $155 $48–$522 $149
2023 $1,751 $167 $52–$557 $160
2024 $1,713 $178 $55–$600 $164
2025 $1,351 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2022–2025
  1. Janssen Pharmaceuticals, Inc $996 39 payments
  2. Otsuka America Pharmaceutical, Inc. $802 38 payments
  3. Teva Pharmaceuticals USA, Inc. $762 55 payments
  4. Lundbeck LLC $541 32 payments
  5. Vanda Pharmaceuticals Inc. $465 22 payments
  6. Ironshore Pharmaceuticals Inc. $390 25 payments
  7. Alkermes, Inc. $388 27 payments
  8. E.R. Squibb & Sons, L.L.C. $370 28 payments
  9. Neurocrine Biosciences, Inc. $347 22 payments
  10. ITI, Inc. $239 13 payments
  11. Other $1,024 58 payments

Every payment, record by record

What the payments were for General payments · program years 2022–2025
  1. Food and Beverage $6,324 359 payments
Products named General payments · program years 2022–2025
  1. ABILIFY MAINTENA $882 41 payments
  2. INVEGA SUSTENNA $729 28 payments
  3. INVEGA TRINZA $695 27 payments
  4. REXULTI $685 33 payments
  5. FANAPT $465 22 payments
  6. HETLIOZ $445 21 payments
  7. COBENFY $362 27 payments
  8. INGREZZA $347 22 payments
  9. LYBALVI $338 25 payments
  10. Austedo XR $327 22 payments
  11. Other $4,264 268 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 38 drugs

Part D claims

1,050

Median for Physician Assistant: 241

Drug cost

$161,882

Median for Physician Assistant: $4,110

Branded share of claims

27.1%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Invega Trinza Paliperidone Palmitate Brand 13 $88,810
Abilify Maintena Aripiprazole Brand 15 $41,525
Trintellix Vortioxetine Hydrobromide Brand 26 $13,294
Divalproex Sodium Er Divalproex Sodium Brand 51 $2,669
Aripiprazole Generic 43 $2,651
Methylphenidate Er Methylphenidate Hcl Brand 11 $1,821
Paliperidone Er Paliperidone Brand 14 $1,064
Hydroxyzine Hcl Generic 53 $1,038
Quetiapine Fumarate Er Quetiapine Fumarate Brand 35 $1,027
Risperidone Generic 74 $929

The 10 drugs with the highest cost, of 38 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Payments and prescribing

First 5 of 23 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
REXULTI
  • Lundbeck LLC $97
  • Otsuka America Pharmaceutical, Inc. $96
$194 — —
Austedo XR
  • Teva Pharmaceuticals USA, Inc. $162
$162 — —
FANAPT
  • Vanda Pharmaceuticals Inc. $142
$142 — —
HETLIOZ
  • Vanda Pharmaceuticals Inc. $142
$142 — —
ABILIFY MAINTENA
  • Lundbeck LLC $80
  • Otsuka America Pharmaceutical, Inc. $39
$119 15 —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See all 23 in the dashboard with a free account

Records

359 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in Ohio

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record